Physician profile
Robert L Long
NPI 1356317002
$3,131.23
in general payments reported to CMS, 2019-2025
21 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $274 · 2021: $1,022 · 2022: $332 · 2023: $443 · 2024: $264 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $875.98 | 2019-2024 | Xtandi |
| Dendreon Pharmaceuticals LLC | $603.98 | 2021-2025 | Provenge |
| Janssen Biotech, INC. | $545.42 | 2019-2025 | Erleada, Akeega |
| Boston Scientific Corporation | $259.66 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $242.44 | 2019-2023 | Edex, Aveed, Xiaflex |
| Myovant Sciences INC. | $184.82 | 2021-2022 | |
| Pfizer INC. | $67.76 | 2019-2022 | |
| Olympus America INC. | $48.27 | 2025 | Itind System |
| Sumitomo Pharma America, INC. | $45.98 | 2023-2024 | Orgovyx |
| Abbvie INC. | $42.32 | 2019-2024 | |
| Abc Home Medical Supply, INC. | $38.33 | 2024-2025 | |
| Tolmar, INC. | $29.16 | 2023 | |
| 180 Medical, INC. | $28.56 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $22.11 | 2019 | |
| Teleflex LLC | $17.67 | 2025 | Barrigel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $15.50 | 2019 | |
| Janssen Scientific Affairs, LLC | $14.89 | 2020 | |
| Hollister Incorporated | $14.33 | 2024 | Infyna Chic |
| Bayer Healthcare Pharmaceuticals INC. | $13.45 | 2023 | |
| Urogen Pharma, INC. | $12.01 | 2020 | |
| Janssen Pharmaceuticals, INC | $8.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.